BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 3207999)

  • 1. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
    Schoeffter P; Hoyer D
    Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
    Bouhelal R; Smounya L; Bockaert J
    Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra.
    Schoeffter P; Waeber C; Palacios JM; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):602-8. PubMed ID: 3216894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Rabin RA; Winter JC
    Eur J Pharmacol; 1993 Apr; 235(2-3):237-43. PubMed ID: 8508905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
    De Vivo M; Maayani S
    J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus.
    Markstein R; Hoyer D; Engel G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):335-41. PubMed ID: 2945992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat.
    Mørk A; Geisler A
    Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists.
    Devivo M; Maayani S
    Eur J Pharmacol; 1985 Dec; 119(3):231-4. PubMed ID: 2936612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.
    Oksenberg D; Peroutka SJ
    Biochem Pharmacol; 1988 Sep; 37(18):3429-33. PubMed ID: 2971358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
    Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
    Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH4ZD10 cells expressing rat 5-HT1A receptors coupled to adenylyl cyclase are a model for the postsynaptic receptors in the rat hippocampus.
    Fowler CJ; Ahlgren PC; Brännström G
    Br J Pharmacol; 1992 Sep; 107(1):141-5. PubMed ID: 1330157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors.
    De Vivo M; Maayani S
    Biochem Pharmacol; 1990 Oct; 40(7):1551-8. PubMed ID: 2222510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis toxin attenuates 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat hippocampal membranes.
    Okada F; Tokumitsu Y; Nomura Y
    J Neurochem; 1989 May; 52(5):1566-9. PubMed ID: 2523468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native 5-HT1B receptors expressed in OK cells display dual coupling to elevation of intracellular calcium concentrations and inhibition of adenylate cyclase.
    Zgombick JM; Branchek TA
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):503-8. PubMed ID: 9840417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.